BLBD vs GBX

BLBD exhibits strong financial health with a Piotroski F-Score of 8/9, indicating robust operational and balance sheet strength. The company is growing rapidly, with 16.9% YoY revenue growth and 51.8% earnings growth, supported by improving margins and high returns on equity and assets. Despite a premium valuation relative to the Graham Number ($26.31) and elevated Price/Book ratio, the stock trades below the growth-based intrinsic value estimate of $113.28 and has a strong analyst consensus. However, recent insider selling activity presents a notable counter-signal to the otherwise positive fundamentals.

GBX presents a conflicted profile with a stable Piotroski F-Score of 4/9 and a defensive Graham Number of $73.05, suggesting significant asset-based value. However, this is heavily offset by a growth-based intrinsic value of $32.83 and alarming fundamental deterioration, including a 69.9% drop in YoY earnings. While the company maintains a strong liquidity position (Current Ratio 3.71) and trades below book value (P/B 0.97), the combination of negative revenue growth and bearish technicals suggests a value trap risk.